GlassScriptPhysician profile
Beth A Cueto
NPI 1467650267
$1,247.98
in general payments reported to CMS, 2019-2025
20 companies · $711 in 2025
The $711 reported for 2025 was more than what 82% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.98 · 2022: $192 · 2023: $192 · 2024: $55.56 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $958.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $278.51 | 2022-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Novo Nordisk INC | $134.55 | 2025 | Wegovy |
| Bridgebio Pharma, INC. | $118.28 | 2025 | Attruby |
| Amgen INC. | $108.44 | 2022-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $86.63 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $70.15 | 2024-2025 | Amvuttra |
| Janssen Pharmaceuticals, INC | $61.92 | 2021 | |
| Baxter Healthcare | $59.79 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $58.06 | 2021-2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $51.55 | 2024-2025 | |
| Glaxosmithkline, LLC. | $38.60 | 2025 | Shingrix |
| Merck Sharp & Dohme LLC | $33.82 | 2021-2022 | |
| Heartflow, INC. | $21.33 | 2025 | |
| Agepha Pharma Fz LLC | $20.50 | 2025 | Lodoco |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.44 | 2025 | Jardiance |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $19.00 | 2023 | |
| Edwards Lifesciences Corporation | $18.28 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $18.18 | 2023 | Camzyos |
| Biosense Webster, INC. | $15.81 | 2023 | Carto 3 |
| Actelion Pharmaceuticals US, INC. | $14.14 | 2023 | Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Cueto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.